To examine the synergistic cytotoxic activity of Tanshinone I and TRAIL, various concentrations of Tanshinone I (0, 20, 40, 80 μM), and/or TRAIL (0, 25, 50 ng) were treated for 24 h in three prostate cancer cells. The gene discussed is TNFSF10; the disease is prostate carcinoma.